Recurrent in-stent restenosis, certainty of its origin, uncertainty about treatment

Davide Piraino1, Giuliana Cimino1, Dario Buccheri1

  • 1Interventional Cardiology, "P. Giaccone" University Hospital of Palermo, Italy.

Insights

Recurrent in-stent restenosis poses a challenge for cardiologists. Drug-coated balloons offer a promising alternative treatment when drug-eluting stents fail, supported by intracoronary imaging insights.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Recurrent in-stent restenosis presents a significant clinical challenge for interventional cardiologists.
  • Current guidelines offer limited direction for managing this complex condition.
  • Understanding the mechanisms of restenosis is crucial for effective treatment strategies.

Purpose of the Study:

  • To review the literature on the treatment of recurrent in-stent restenosis.
  • To explore the role of intracoronary imaging in understanding restenosis mechanisms.
  • To evaluate drug-coated balloons as a treatment option for recurrent in-stent restenosis.

Main Methods:

  • Comprehensive literature search on recurrent in-stent restenosis.
  • Analysis of studies utilizing intracoronary imaging for mechanism elucidation.
  • Review of clinical outcomes associated with drug-coated balloons and drug-eluting stents.

Main Results:

  • Intracoronary imaging provides valuable insights into the underlying causes of in-stent restenosis.
  • Drug-coated balloons demonstrate potential as an effective treatment, particularly when repeat drug-eluting stent implantation is unsuccessful.
  • The management of recurrent in-stent restenosis requires tailored approaches beyond standard guidelines.

Conclusions:

  • Recurrent in-stent restenosis management remains complex, lacking definitive guideline-based indications.
  • Intracoronary imaging aids in understanding restenosis, guiding therapeutic decisions.
  • Drug-coated balloons represent a viable and thoughtful therapeutic option for refractory cases.

Related Concept Videos

Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
506
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
422
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357